Gabapentin indications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Reverted edits by AngelSlayerWQD5 (talk) to last revision by LBiller |
||
| Line 9: | Line 9: | ||
<br> | <br> | ||
===Postherpetic Neuralgia=== | ===Postherpetic Neuralgia=== | ||
Neurontin (gabapentin) is indicated for the management of postherpetic neuralgia in adults. | Neurontin (gabapentin) is indicated for the management of postherpetic neuralgia in adults. ''[[Gabapentin indications#List of indications|Return to top]]'' | ||
<br> | <br> | ||
===Epilepsy=== | ===Epilepsy=== | ||
Neurontin (gabapentin) is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Neurontin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 –12 years. ''[[Gabapentin indications#List of indications|Return to top]]'' | Neurontin (gabapentin) is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Neurontin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 –12 years. ''[[Gabapentin indications#List of indications|Return to top]]'' | ||
Latest revision as of 17:57, 20 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
List of indications
Postherpetic Neuralgia
Epilepsy
Postherpetic Neuralgia
Neurontin (gabapentin) is indicated for the management of postherpetic neuralgia in adults. Return to top
Epilepsy
Neurontin (gabapentin) is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Neurontin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 –12 years. Return to top
Adapted from the FDA Package Insert.